经导管与外科主动脉瓣置换的发作期支付及与病例量的关系
该研究评估了2012至2016年密歇根州6359例接受TAVR(17家医院,n=1655)或SAVR(33家医院,n=4704)的蓝十字蓝盾和Medicare按服务付费受益人,比较90天出院后总发作期支付。TAVR的发作期支付高于SAVR,尽管住院时间更短;SAVR高容量中心支付低于低容量中心,而TAVR中心未见容量-支付关系。
要点
- TAVR发作期支付为69,388±22,259美元,高于SAVR的66,683±27,377美元(p<0.001)。
- SAVR高容量中心发作期支付较低容量中心低5.0%(3,255美元;p=0.01)。
- TAVR中心未发现容量与支付的关系。
核心结论
- 尽管TAVR住院时间更短,其发作期支付仍高于SAVR。
- SAVR中心容量与支付呈负相关,但容量并非TAVR支付的驱动因素。
研究设计与样本
- 回顾性评估2012至2016年密歇根州蓝十字蓝盾和Medicare按服务付费受益人。
- TAVR组来自17家医院,n=1655;SAVR组来自33家医院,n=4704。
- 支付涵盖至出院后90天,经价格标准化和风险调整。
- 各中心按手术量三分位分组,分别比较TAVR和SAVR最低与最高三分位的支付。
主要发现
- TAVR发作期支付为69,388±22,259美元,SAVR为66,683±27,377美元(p<0.001)。
- TAVR平均住院时间为6.2±5.6天,SAVR为10.2±7.5天(p<0.001)。
- TAVR的索引住院支付比SAVR高4,374美元(p<0.001),再入院支付低1,150美元(p=0.001),急性后期护理支付低739美元(p=0.004),专业支付相似。
- SAVR高容量中心发作期支付较低容量中心低5.0%(3,255美元;p=0.01),住院时间更短(10.0±7.5天 vs 11.1±7.9天,p=0.002)。
- TAVR中心未发现容量-支付关系。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcatheter aortic valve replacement (TAVR) has increased in volume as an alternative to surgical aortic valve replacement (SAVR). Comparisons of total episode expenditures, although largely ignored thus far, will be key to the value proposition for payers. METHODS: We evaluated 6,359 Blue Cross Blue Shield of Michigan and Medicare fee-for-service beneficiaries undergoing TAVR (17 hospitals, n = 1,655) or SAVR (33 hospitals, n = 4,704) in Michigan between 2012 and 2016. Payments through 90 post-discharge days between TAVR and SAVR were price-standardized and risk-adjusted. Centers were divided into terciles of procedural volume separately for TAVR and SAVR, and payments were compared between lowest and highest terciles. RESULTS: Payments (± SD) were higher for TAVR than SAVR ($69,388 ± $22,259 versus $66,683 ± $27,377, p < 0.001), while mean hospital length of stay was shorter for TAVR (6.2 ± 5.6 versus 10.2 + 7.5 days, p < 0.001). Index hospitalization payments were $4,374 higher for TAVR (p < 0.001), whereas readmission and post-acute care payments were $1,150 (p = 0.001) and $739 (p = 0.004) lower, respectively, and professional payments were similar. For SAVR, high-volume centers had lower episode payments (difference: 5.0%, $3,255; p = 0.01) and shorter length of stay (10.0 ± 7.5 versus 11.1 ± 7.9 days, p = 0.002) than low volume centers. In contrast, we found no volume-payment relationship among TAVR centers. CONCLUSIONS: Episode payments were higher for TAVR, despite shorter length of stay. Although not a driver for TAVR, center SAVR volume was inversely associated with payments. These data will be increasingly important to address value-based reimbursement in valve replacement surgery.
引用
- Brescia AA, Syrjamaki JD, Regenbogen SE, et al. Transcatheter Versus Surgical Aortic Valve Replacement Episode Payments and Relationship to Case Volume. Ann Thorac Surg. 2018. PMID: 30179625. doi:10.1016/j.athoracsur.2018.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。